Cambridge Bioscience is proud to announce its partnership with nanoComposix, a global leader in high-purity, monodisperse nanomaterials. This collaboration will bring nanoComposix's cutting-edge nanoparticles—including gold, silver, and silica—to the UK and Ireland market, supporting a diverse range of research and industrial applications.
With a reputation for precision and consistent quality, nanoComposix delivers solutions that meet the needs of researchers and manufacturers alike. Gold nanoparticles offer exceptional plasmonic optical properties and flexible surface functionalisation, making them ideal for applications like immunodiagnostics and biosensors. Silver nanoparticles stand out for their optical and antimicrobial properties, excelling in biosensors and photovoltaics. Meanwhile, silica nanoparticles provide biocompatibility and versatility, supporting areas such as drug delivery and DNA/RNA extraction.
This partnership underscores Cambridge Bioscience's commitment to providing UK researchers with world-class tools to advance innovation. The addition of nanoComposix's nanomaterials to our portfolio represents a significant step in expanding access to high-performance solutions.
For more information about this exciting partnership and product availability, contact our nanoComposix specialists.